Category: ACT-AD (Accelerate Cure/Treatments for Alzheimer’s Disease)

October 31, 2018

Alzheimer’s Disease (ACT-AD) Coalition Goes to Barcelona

In October, the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) coalition, which is chaired by the Alliance for Aging Research, attended the …
June 15, 2018

ACT-AD Coalition Letter on FDA Early Alzheimer’s Disease Guidance

The majority of clinical trials conducted in Alzheimer’s disease have been for patients who received a definitive diagnosis after becoming…
August 10, 2017

Alzheimer’s Association International Conference Recap

Last month, the Alzheimer’s Association International Conference was held in London, England. While we are still years away from discovering a cure, the conference highlights the steady efforts of researchers and scientists to better understand the devastating disease.
July 20, 2017

Webinar on Research Framework for Alzheimer’s Disease/July 25

On Tuesday, July 25, the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) Coalition will hold a one-hour webinar on Alzheimer's disease research framework, featuring expert perspectives.
June 19, 2017

Alzheimer’s Disease Begins Before Symptoms Start, Researchers Say

Researchers at the Keck School of Medicine of the University of Southern California may have discovered Alzheimer's disease in its earliest stage. Their findings provide greater insight into the disease and could offer new ways to treat the devastating disease.
March 24, 2017

ACT-AD Coalition’s Webinar on Symptomatic Relief for Alzheimer’s Available Now

On March 15, the Accelerate Cure/Treatments for Alzheimer's Disease (ACT-AD) Coalition hosted a webinar on symptomatic relief for Alzheimer's disease. An archived video of the webinar is now available. 
March 6, 2017

Webinar on Symptomatic Relief for Alzheimer’s/March 15

On Wednesday, March 15, at 12 p.m. EST, the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) Coalition will hold a one-hour webinar on symptomatic relief for Alzheimer’s disease, featuring expert presentations.
November 22, 2016

ACT-AD Coalition Holds Ninth Annual Meeting

On November 16, the ACT-AD (Accelerate Cure/Treatments for Alzheimer’s Disease) Coalition hosted its Ninth Annual FDA/Alzheimer’s Disease Allies Meeting in North Bethesda, Md., to discuss the current state of Alzheimer’s disease treatment development.
November 16, 2016

Experts Explore Federal Agency Collaborations to Close Alzheimer’s Disease Research Gaps at ACT-AD Coalition Annual Meeting

Today, senior representatives from the U.S. Food and Drug Administration (FDA) and the National Institute on Aging at the National Institutes of Health (NIH) joined with advocates, federal colleagues, researchers, and industry to explore collaborations for advancing the most up-to-date knowledge in Alzheimer’s disease research. 
November 16, 2016

9th Annual FDA/Alzheimer’s Disease Allies Meeting

The ACT-AD Coalition will hold its 9th Annual FDA/Alzheimer’s Disease Allies Meeting on Wednesday, November 16, 2016 at the Bethesda North Marriott Hotel & Conference Center.